出生前検査と新生児スクリーニングの世界市場レポート 2025年

出生前検査と新生児スクリーニングの市場規模は今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は12.2％で、110億8,000万米ドルに成長します。予測期間の成長は、遺伝カウンセリング、技術の進歩、ポイントオブケア検査、遠隔医療、遠隔モニタリングに起因すると考えられます。予測期間における主な動向には、非侵襲的出生前検査（nipt）、着床前遺伝学的検査（pgt）、遠隔医療相談、妊産婦血液検査、ヘモグロビノパチー、鎌状赤血球スクリーニングなどがあります。

出生前検査と新生児スクリーニング市場の成長は、乳幼児における遺伝性疾患の高い有病率によって大きく牽引されています。世界保健機関は、サラセミア、鎌状赤血球貧血、血友病、嚢胞性線維症、テイ・サックス病、脆弱X症候群、ハンチントン病などの遺伝病を特定しています。なかでも、アフリカ系、アメリカ系、キューバ系、中米系、サウジアラビア系、インド系の祖先を持つ人に多く発症する鎌状赤血球貧血は、特に広く普及しています。例えば、2023年2月、米国の研究機関であるレディ小児ゲノム医学研究所は、レディ小児病院で実施された調査の結果、乳児死亡の41％が一遺伝子座（メンデル）遺伝病に起因していたことを報告しました。このように乳幼児における遺伝性疾患の有病率が高まっていることが、出生前検査や新生児スクリーニングの需要を高めています。

出生前検査と新生児スクリーニング市場は、出生率の増加により成長の態勢を整えています。出生前検査は出生前に胎児の健康状態を評価し、新生児スクリーニングは出生直後に特定の病状を検出し、必要な場合に早期介入を可能にします。例えば、2024年4月、米国の政府機関である疾病対策予防センター（CDC）が発表した報告書によると、2023年の帝王切開分娩率は4年連続で上昇し、32.4％に達したことが明らかになりました。さらに、低リスク帝王切開分娩の割合は26.6％に上昇しました。したがって、出生率の上昇は出生前検査および新生児スクリーニング市場の主要な促進要因です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界出生前検査と新生児スクリーニング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の出生前検査と新生児スクリーニング市場：成長率分析
• 世界の出生前検査と新生児スクリーニング市場の実績：規模と成長, 2019-2024
• 世界の出生前検査と新生児スクリーニング市場の予測：規模と成長, 2024-2029, 2034F
• 世界出生前検査と新生児スクリーニング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の出生前検査と新生児スクリーニング市場診断タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 非侵襲的
• 侵襲的
• 世界の出生前検査と新生児スクリーニング市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• スクリーニング技術
• 診断技術
• 世界の出生前検査と新生児スクリーニング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 診断センター
• 世界の出生前検査と新生児スクリーニング市場非侵襲性のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液検査（遊離細胞DNA検査）
• 超音波
• 母体血清スクリーニング
• 世界の出生前検査と新生児スクリーニング市場、侵襲性のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 羊水穿刺
• 絨毛膜絨毛採取（CVS）
• 臍帯穿刺

第7章 地域別・国別分析

• 世界の出生前検査と新生児スクリーニング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の出生前検査と新生児スクリーニング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 出生前検査と新生児スクリーニング市場：競合情勢
• 出生前検査と新生児スクリーニング市場：企業プロファイル
  • PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Laboratory Corporation of America Holdings（LabCorp）Overview, Products and Services, Strategy and Financial Analysis
  • Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Centogene AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cradle Genomics Inc.
• Roche Diagnostics International AG
• Quest Diagnostics Incorporated
• Baebies Inc.
• Progenity Inc.
• Ravgen Inc.
• Strand Life Sciences Pvt. Ltd.
• Eurofins Scientific
• Illumina Inc.
• Agilent Technologies Inc.
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd.
• Bio-Rad Laboratories Inc.
• General Electric Company
• Siemens Healthineers AG

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 出生前検査と新生児スクリーニング市場2029：新たな機会を提供する国
• 出生前検査と新生児スクリーニング市場2029：新たな機会を提供するセグメント
• 出生前検査と新生児スクリーニング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Prenatal testing and newborn screening are medical practices designed to evaluate the health of both the fetus during pregnancy and the newborn after birth. Prenatal testing encompasses a range of assessments, such as blood tests and ultrasounds, to identify potential genetic or developmental disorders in the fetus. Newborn screening involves conducting tests shortly after birth to detect metabolic, genetic, and endocrine disorders, enabling early intervention and treatment to enhance health outcomes for infants.

The primary diagnostic categories within prenatal testing and newborn screening encompass non-invasive and invasive methods. Invasive diagnostic testing involves procedures that penetrate the skin or body, including techniques such as blood testing, biopsies, and colonoscopies. These diagnostic methods leverage various technologies, including screening and diagnostic technology, and are applied across a range of sectors, including hospitals and diagnostic centers.

The prenatal testing & newborn screening market research report is one of a series of new reports from The Business Research Company that provides prenatal testing & newborn screening market statistics, including prenatal testing & newborn screening industry global market size, regional shares, competitors with prenatal testing & newborn screening market share, detailed prenatal testing & newborn screening market segments, market trends and opportunities, and any further data you may need to thrive in the prenatal testing and newborn screening tests industry. This prenatal testing and newborn screening tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The prenatal testing & newborn screening market size has grown rapidly in recent years. It will grow from $6.24 billion in 2024 to $6.99 billion in 2025 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to advancements in genetic testing, increased maternal age, awareness and education, healthcare policy and regulations.

The prenatal testing & newborn screening market size is expected to see rapid growth in the next few years. It will grow to $11.08 billion in 2029 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to genetic counseling, technological advancements, point-of-care testing, telehealth and remote monitoring. Major trends in the forecast period include non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, hemoglobinopathies and sickle cell screening.

The growth of the prenatal testing and newborn screening market is significantly driven by the high prevalence of genetic diseases in infants. The World Health Organization identifies genetic diseases such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, and Huntington's disease. Among these, Sickle Cell Anemia, which predominantly affects individuals with African, American, Cuban, Central American, Saudi Arabian, and Indian ancestry, is particularly widespread. For instance, in February 2023, the Rady Children's Institute for Genomic Medicine, a U.S.-based research institute, reported that a study conducted at Rady Children's Hospital found that 41% of infant deaths were attributed to single-locus (Mendelian) genetic diseases. This heightened prevalence of genetic diseases in infants has driven the demand for prenatal testing and newborn screening.

The prenatal testing and newborn screening market is poised for growth due to an increase in birth rates. Prenatal testing assesses the health of fetuses before birth, while newborn screening detects specific medical conditions shortly after birth, enabling early intervention when necessary. For example, in April 2024, a report published by the Centers for Disease Control and Prevention (CDC), a U.S.-based government agency, revealed that the cesarean delivery rate increased for the fourth consecutive year in 2023, reaching 32.4%. Additionally, the rate of low-risk cesarean deliveries rose to 26.6%. Therefore, the rising birth rate is a key driver of the prenatal testing and newborn screening market.

Leading companies in the prenatal testing and newborn screening market are focusing on introducing innovative programs that leverage rapid Whole Genome Sequencing (rWGS) technology to quickly and accurately detect genetic disorders in newborns, allowing for early diagnosis and intervention to improve health outcomes. rWGS technology is an advanced genomic technique that rapidly sequences an individual's entire genome. Unlike traditional genetic testing methods that target specific genes or regions, rWGS captures all the DNA in a person's genome to identify genetic variants associated with diseases or disorders. For example, in June 2022, Rady Children's Institute for Genomic Medicine, a U.S.-based organization, launched BeginNGS, a novel program aimed at identifying and diagnosing approximately 400 genetic disorders with known treatment options before symptoms appear. BeginNGS is optimizing genomic sequencing processes and plans to expand testing capabilities to include around 1,000 disorders. The ultimate goal is to screen 3.7 million newborns annually, making this practice a standard procedure in hospitals nationwide.

Key players in the prenatal testing and newborn screening market are focused on developing innovative newborn screening devices to enhance the early detection of genetic, metabolic, and other health conditions, enabling timely interventions and improved health outcomes for newborns. Newborn screening point-of-care devices are designed to provide faster, more accessible, and cost-effective screening for newborns, accommodating the seven standard newborn screening tests conducted globally. For example, in September 2023, Mylab Discovery Solutions Pvt. Ltd., an India-based company, launched MyNeoShield, a newborn screening point-of-care device. MyNeoShield is designed to be low-cost, priced at about one-fifth of existing solutions, which typically range from ₹50 lakhs to ₹7 crores. By bringing testing directly to healthcare providers, MyNeoShield aims to improve access to critical health services for newborns, particularly in underserved regions.

In January 2022, Exact Sciences Corp., a molecular diagnostics company, completed the acquisition of Prevention Genetics for $190 million. This acquisition enhances Exact Sciences' advanced cancer diagnostics portfolio and allows the company to enter the hereditary cancer testing (HCT) market. Prevention Genetics, a company specializing in clinical DNA (genetic) tests for prenatal testing and newborn screening, complements Exact Sciences' capabilities and expands its market presence.

Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

North America was the largest region in the prenatal testing & newborn screening market in 2024. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the prenatal testing & newborn screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The prenatal testing & newborn screening market includes revenues earned by entities by providing blood test services, hearing test services, CCHD screening tests, and non-invasive tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Prenatal Testing & Newborn Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on prenatal testing & newborn screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for prenatal testing & newborn screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The prenatal testing & newborn screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Diagnostic Type: Non-Invasive; Invasive
• 2) By Technology: Screening Technology; Diagnostic Technology
• 3) By End user: Hospitals; Diagnostic centers
• Subsegments:
• 1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing); Ultrasound; Maternal Serum Screening
• 2) By Invasive: Amniocentesis; Chorionic Villus Sampling (CVS); Cordocentesis
• Companies Mentioned: PerkinElmer Inc.; Laboratory Corporation of America Holdings (LabCorp); Natera Inc.; Invitae Corporation; Centogene AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Prenatal Testing & Newborn Screening Market Characteristics

3. Prenatal Testing & Newborn Screening Market Trends And Strategies

4. Prenatal Testing & Newborn Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Prenatal Testing & Newborn Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Prenatal Testing & Newborn Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Prenatal Testing & Newborn Screening Market Growth Rate Analysis
• 5.4. Global Prenatal Testing & Newborn Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Prenatal Testing & Newborn Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Prenatal Testing & Newborn Screening Total Addressable Market (TAM)

6. Prenatal Testing & Newborn Screening Market Segmentation

• 6.1. Global Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Non-Invasive
• Invasive
• 6.2. Global Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Screening Technology
• Diagnostic Technology
• 6.3. Global Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Diagnostic centers
• 6.4. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Non-Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Tests (C ell-Free DNA Testing)
• Ultrasound
• Maternal Serum Screening
• 6.5. Global Prenatal Testing & Newborn Screening Market, Sub-Segmentation Of Invasive, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amniocentesis
• Chorionic Villus Sampling (CVS)
• Cordocentesis

7. Prenatal Testing & Newborn Screening Market Regional And Country Analysis

• 7.1. Global Prenatal Testing & Newborn Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Prenatal Testing & Newborn Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prenatal Testing & Newborn Screening Market

• 8.1. Asia-Pacific Prenatal Testing & Newborn Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prenatal Testing & Newborn Screening Market

• 9.1. China Prenatal Testing & Newborn Screening Market Overview
• 9.2. China Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prenatal Testing & Newborn Screening Market

• 10.1. India Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prenatal Testing & Newborn Screening Market

• 11.1. Japan Prenatal Testing & Newborn Screening Market Overview
• 11.2. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prenatal Testing & Newborn Screening Market

• 12.1. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prenatal Testing & Newborn Screening Market

• 13.1. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prenatal Testing & Newborn Screening Market

• 14.1. South Korea Prenatal Testing & Newborn Screening Market Overview
• 14.2. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prenatal Testing & Newborn Screening Market

• 15.1. Western Europe Prenatal Testing & Newborn Screening Market Overview
• 15.2. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prenatal Testing & Newborn Screening Market

• 16.1. UK Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prenatal Testing & Newborn Screening Market

• 17.1. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prenatal Testing & Newborn Screening Market

• 18.1. France Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prenatal Testing & Newborn Screening Market

• 19.1. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prenatal Testing & Newborn Screening Market

• 20.1. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prenatal Testing & Newborn Screening Market

• 21.1. Eastern Europe Prenatal Testing & Newborn Screening Market Overview
• 21.2. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prenatal Testing & Newborn Screening Market

• 22.1. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prenatal Testing & Newborn Screening Market

• 23.1. North America Prenatal Testing & Newborn Screening Market Overview
• 23.2. North America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prenatal Testing & Newborn Screening Market

• 24.1. USA Prenatal Testing & Newborn Screening Market Overview
• 24.2. USA Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prenatal Testing & Newborn Screening Market

• 25.1. Canada Prenatal Testing & Newborn Screening Market Overview
• 25.2. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prenatal Testing & Newborn Screening Market

• 26.1. South America Prenatal Testing & Newborn Screening Market Overview
• 26.2. South America Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prenatal Testing & Newborn Screening Market

• 27.1. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prenatal Testing & Newborn Screening Market

• 28.1. Middle East Prenatal Testing & Newborn Screening Market Overview
• 28.2. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prenatal Testing & Newborn Screening Market

• 29.1. Africa Prenatal Testing & Newborn Screening Market Overview
• 29.2. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Diagnostic Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Prenatal Testing & Newborn Screening Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Prenatal Testing & Newborn Screening Market, Segmentation By End user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prenatal Testing & Newborn Screening Market Competitive Landscape And Company Profiles

• 30.1. Prenatal Testing & Newborn Screening Market Competitive Landscape
• 30.2. Prenatal Testing & Newborn Screening Market Company Profiles
  • 30.2.1. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Natera Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Invitae Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Centogene AG Overview, Products and Services, Strategy and Financial Analysis

31. Prenatal Testing & Newborn Screening Market Other Major And Innovative Companies

• 31.1. Cradle Genomics Inc.
• 31.2. Roche Diagnostics International AG
• 31.3. Quest Diagnostics Incorporated
• 31.4. Baebies Inc.
• 31.5. Progenity Inc.
• 31.6. Ravgen Inc.
• 31.7. Strand Life Sciences Pvt. Ltd.
• 31.8. Eurofins Scientific
• 31.9. Illumina Inc.
• 31.10. Agilent Technologies Inc.
• 31.11. Thermo Fisher Scientific Inc.
• 31.12. F. Hoffmann-La Roche Ltd.
• 31.13. Bio-Rad Laboratories Inc.
• 31.14. General Electric Company
• 31.15. Siemens Healthineers AG

32. Global Prenatal Testing & Newborn Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prenatal Testing & Newborn Screening Market

34. Recent Developments In The Prenatal Testing & Newborn Screening Market

35. Prenatal Testing & Newborn Screening Market High Potential Countries, Segments and Strategies

• 35.1 Prenatal Testing & Newborn Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Prenatal Testing & Newborn Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Prenatal Testing & Newborn Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer